JP2022538425A5 - - Google Patents
Info
- Publication number
- JP2022538425A5 JP2022538425A5 JP2021576820A JP2021576820A JP2022538425A5 JP 2022538425 A5 JP2022538425 A5 JP 2022538425A5 JP 2021576820 A JP2021576820 A JP 2021576820A JP 2021576820 A JP2021576820 A JP 2021576820A JP 2022538425 A5 JP2022538425 A5 JP 2022538425A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025076601A JP2025118764A (ja) | 2019-06-27 | 2025-05-02 | ４－１ｂｂ共刺激性ドメインを有するキメラ抗原受容体 |
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962867503P | 2019-06-27 | 2019-06-27 | |
| US62/867,503 | 2019-06-27 | ||
| KRPCT/KR2019/010244 | 2019-08-12 | ||
| PCT/KR2019/010244 WO2020032784A1 (ko) | 2018-08-10 | 2019-08-12 | Hla-dr에 결합하는 키메라 항원 수용체 및 car-t 세포 |
| US16/715,462 | 2019-12-16 | ||
| US16/715,462 US11013765B2 (en) | 2018-08-10 | 2019-12-16 | Chimeric antigen receptor that binds HLA-DR and CAR-T cell |
| US202062991493P | 2020-03-18 | 2020-03-18 | |
| US62/991,493 | 2020-03-18 | ||
| US202063004827P | 2020-04-03 | 2020-04-03 | |
| US63/004,827 | 2020-04-03 | ||
| US202063043237P | 2020-06-24 | 2020-06-24 | |
| US63/043,237 | 2020-06-24 | ||
| PCT/IB2020/056097 WO2020261231A1 (en) | 2019-06-27 | 2020-06-26 | Chimeric antigen receptor with 4-1bb costimulatory domain |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025076601A Division JP2025118764A (ja) | 2019-06-27 | 2025-05-02 | ４－１ｂｂ共刺激性ドメインを有するキメラ抗原受容体 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022538425A JP2022538425A (ja) | 2022-09-02 |
| JP2022538425A5 true JP2022538425A5 (https=) | 2023-06-15 |
| JPWO2020261231A5 JPWO2020261231A5 (https=) | 2023-06-15 |
| JP7829911B2 JP7829911B2 (ja) | 2026-03-16 |
Family
ID=74061779
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021576820A Active JP7829911B2 (ja) | 2019-06-27 | 2020-06-26 | ４－１ｂｂ共刺激性ドメインを有するキメラ抗原受容体 |
| JP2025076601A Withdrawn JP2025118764A (ja) | 2019-06-27 | 2025-05-02 | ４－１ｂｂ共刺激性ドメインを有するキメラ抗原受容体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025076601A Withdrawn JP2025118764A (ja) | 2019-06-27 | 2025-05-02 | ４－１ｂｂ共刺激性ドメインを有するキメラ抗原受容体 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP3990626A4 (https=) |
| JP (2) | JP7829911B2 (https=) |
| CN (2) | CN114080452B (https=) |
| AU (1) | AU2020307673A1 (https=) |
| BR (1) | BR112021026406A2 (https=) |
| CA (1) | CA3144875A1 (https=) |
| MX (1) | MX2021015967A (https=) |
| WO (1) | WO2020261231A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3835320A4 (en) * | 2018-08-10 | 2022-06-01 | Eutilex Co., Ltd. | Chimeric antigen receptor binding to hla-dr, and car-t cell |
| EP3962527A4 (en) | 2019-04-30 | 2023-11-01 | Senti Biosciences, Inc. | CHIMERIC RECEPTORS AND METHODS OF USE THEREOF |
| KR102671410B1 (ko) * | 2021-03-03 | 2024-06-04 | 진화섭 | RANK 리간드(RANK ligand)에 특이적으로 결합하는 키메릭 항원 수용체 및 이의 용도 |
| JP2025509769A (ja) * | 2022-03-15 | 2025-04-11 | ニューヨーク・ゲノム・センター，インコーポレーテッド | 改善した免疫療法のための融合タンパク質を含む方法及び組成物 |
| WO2025103439A1 (zh) * | 2023-11-16 | 2025-05-22 | 广州瑞风生物科技有限公司 | 一种嵌合抗原受体及其应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050113564A1 (en) * | 2003-11-05 | 2005-05-26 | St. Jude Children's Research Hospital | Chimeric receptors with 4-1BB stimulatory signaling domain |
| JP4331227B2 (ja) * | 2004-07-09 | 2009-09-16 | 中外製薬株式会社 | 抗グリピカン３抗体 |
| AU2013204922B2 (en) * | 2012-12-20 | 2015-05-14 | Celgene Corporation | Chimeric antigen receptors |
| WO2014160627A1 (en) * | 2013-03-25 | 2014-10-02 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-cd276 polypeptides, proteins, and chimeric antigen receptors |
| WO2015069922A2 (en) * | 2013-11-06 | 2015-05-14 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Alk antibodies, conjugates, and chimeric antigen receptors, and their use |
| KR101605421B1 (ko) * | 2014-03-05 | 2016-03-23 | 국립암센터 | B 세포 림프종 세포를 특이적으로 인지하는 단일클론항체 및 이의 용도 |
| MX383150B (es) * | 2014-06-02 | 2025-03-13 | Us Health | Receptores quiméricos de antígeno que tienen como diana a cd-19. |
| US10195272B2 (en) * | 2015-03-02 | 2019-02-05 | The Nemours Foundation | Adoptive t-cell therapy using FcεRI-based chimeric antigen receptors for treating IgE-mediated allergic diseases |
| JP7010473B2 (ja) * | 2015-06-04 | 2022-02-10 | ユニバーシティ オブ サザン カリフォルニア | Ｌｙｍ－１およびｌｙｍ－２標的化ｃａｒ細胞免疫療法 |
| CN114181960B (zh) * | 2015-10-09 | 2024-08-23 | 美天施生物科技有限公司 | 嵌合抗原受体和使用方法 |
| CN105906720A (zh) * | 2016-05-16 | 2016-08-31 | 武汉汉密顿生物科技股份有限公司 | 靶向性嵌合抗原受体修饰的免疫细胞及其制备方法和应用 |
| CN106279438B (zh) * | 2016-08-24 | 2019-10-22 | 北京领柯生物科技有限公司 | 新型嵌合抗原受体及其用途 |
| CN108165568B (zh) * | 2016-12-07 | 2020-12-08 | 上海恒润达生生物科技有限公司 | 一种培养CD19CAR-iNKT细胞方法及用途 |
| WO2018106993A1 (en) * | 2016-12-09 | 2018-06-14 | H. Lee Moffitt Cancer Center And Research Institute Inc. | Tlr9-binding chimeric antigen receptors |
| WO2018132513A1 (en) * | 2017-01-10 | 2018-07-19 | The General Hospital Corporation | T cells experessing a chimeric antigen receptor |
| JP2020508080A (ja) * | 2017-02-21 | 2020-03-19 | ユーティレックス カンパニー リミテッド | Ｈｌａ−ｄｒ ｃａｒ−ｔ組成物ならびにその作製方法および使用方法 |
| WO2018156711A1 (en) * | 2017-02-22 | 2018-08-30 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Il13ra2-binding chimeric antigen receptors |
| CN108728459B (zh) * | 2017-04-24 | 2023-08-04 | 上海恒润达生生物科技股份有限公司 | 靶向cd19的嵌合抗原受体并联合表达il-15的方法和用途 |
| WO2018236909A1 (en) * | 2017-06-20 | 2018-12-27 | La Jolla Institute For Allergy And Immunology | Engineered t-cell receptors and methods of their use in modulating inflammatory responses and treating atherosclerosis |
| US10442867B2 (en) * | 2017-07-31 | 2019-10-15 | Lentigen Technology, Inc. | Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy |
| CN108715859B (zh) * | 2018-05-31 | 2021-08-03 | 中国医学科学院血液病医院(中国医学科学院血液学研究所) | 靶向cd22的嵌合抗原受体及其应用 |
| JPWO2020017479A1 (ja) * | 2018-07-17 | 2021-08-02 | ノイルイミューン・バイオテック株式会社 | 抗ｇｐｃ３一本鎖抗体を含むｃａｒ |
-
2020
- 2020-06-26 MX MX2021015967A patent/MX2021015967A/es unknown
- 2020-06-26 CN CN202080047355.XA patent/CN114080452B/zh active Active
- 2020-06-26 WO PCT/IB2020/056097 patent/WO2020261231A1/en not_active Ceased
- 2020-06-26 CA CA3144875A patent/CA3144875A1/en active Pending
- 2020-06-26 JP JP2021576820A patent/JP7829911B2/ja active Active
- 2020-06-26 EP EP20831651.3A patent/EP3990626A4/en active Pending
- 2020-06-26 AU AU2020307673A patent/AU2020307673A1/en active Pending
- 2020-06-26 CN CN202411914064.2A patent/CN119955732A/zh active Pending
- 2020-06-26 BR BR112021026406A patent/BR112021026406A2/pt unknown
-
2025
- 2025-05-02 JP JP2025076601A patent/JP2025118764A/ja not_active Withdrawn